From Animal Source to Full-Chain Controllability: Cloud-Clone Primary Cells for Customized Research Needs
In-house SPF animal facility enables traceable, tailor-made primary cell solutions for life-science and drug-discovery projects Cloud-Clone has developed a self-operated platform for custom primary-cell production for customized research needs, addressing the shortage of commercial suppliers who only offer off-the-shelf standardized batches and cannot meet sophisticated custom requirements tied to animal origin. The company has developed an in-vitro model for life-science studies and new-drug development using primary cells, which are widely used in pharmacological and toxicological assays, disease-mechanism dissection, target validation and drug screening. Cloud-Clon has over 600 cell types across over 4 000 batches and operates a 1 200 m² in-house SPF-grade experimental-animal center with complete production and usage licenses for laboratory animals. The firm also provides full-chain independent control and end-to-end traceability spanning animal breeding, husbandry, tissue harvesting, primary- cell isolation and purification, culture-quality control, and cold-chain delivery.
Publicados : 4 horas atrás por SuKi Duan no Health Science
HUSTON, TX, UNITED STATES, October 26, 2026 /EINPresswire.com/ -- Primary cells serve as the gold-standard in-vitro model for life-science studies and new-drug development, faithfully recapitulating n... [11501 symbols]
